Skip to Content

DROXIA 6336 DROXIA 6336 (Droxia 300 mg)

Generic Name: hydroxyurea

Pill with imprint DROXIA 6336 DROXIA 6336 is Purple, Capsule-shape and has been identified as Droxia 300 mg. It is supplied by Bristol-Myers Squibb.

Droxia is used in the treatment of anemia, sickle cell; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DROXIA 6336 DROXIA 6336

Droxia 300 mg DROXIA 6336 DROXIA 6336
Droxia 300 mg DROXIA 6336 DROXIA 6336
Droxia 300 mg DROXIA 6336 DROXIA 6336
Droxia 300 mg DROXIA 6336 DROXIA 6336

Droxia

Generic Name
hydroxyurea
Imprint
DROXIA 6336 DROXIA 6336
Strength
300 mg
Color
Purple
Size
19.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Antimetabolites
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Bristol-Myers Squibb
National Drug Code (NDC)
00003-6336
Inactive Ingredients
citric acid monohydrate, gelatin, magnesium stearate, sodium phosphate, titanium dioxide, D&C Red No. 28, D&C Red No. 33, FD&C Blue No. 1

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.